Business
Astrana Health, Inc. Reports Third Quarter 2025 Results
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year,
About this update from Astrana Health Inc.
[{"type":"text","content":"\n Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET\n \n \n \n Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidance\n \n \n Reports adjusted EBITDA of $68.5 million, at the higher end of guidance\n \n \n Closes Prospect Health acquisition where standalone third quarter performance exceeded expectations\n \n \n Continuing to control medical costs well; reiterating full-year trend expectations\n \n \n Updates full-year 2025 guidance to account for full-risk contract delays unrelated to core performance\n \n \n \n ALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. (\"Astrana,\" and together with its subsidiaries and affiliated entities, the \"Company\") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2025.\n \n \n \n \n \n \n \n \"Astrana delivered solid third quarter results and demonstrated strong momentum in our first quarter of combined operations with Prospect Health,\" said Brandon Sim, President and Chief Executive Officer. \"Prospect's performance exceeded our expectations, and integration is progressing well, expanding our scale, capabilities, and physician reach across key markets. While our full-year outlook reflects the updated timing of certain full-risk contract transitions, which we expect to complete in the first quarter of 2026, underlying clinical and cost trend performance across both the legacy Astrana and Prospect businesses remain strong. We continue to execute with discipline and focus on building a more coordinated, high-quality, and accessible care delivery platform for the long term.\"\n \n Financial Highlights for Third Quarter Ended September 30, 2025:\n \n \n All comparisons are to the three months ended September 30, 2024 unless otherwise stated.\n \n Total revenue of $956.0 million, up 100% from $478.7 million\n Care Partners revenue of $897.7 million, up 97% from $455.8 million\n Net income attributable to Astrana of $0.4 million\n Earnings per share - diluted of $0.01\n Adjusted EBITDA(1) of $68.5 million, up 52% from $45.2 million\n \n \n Financial Highlights for Nine Months Ended Septem...